Press Releases
Absci Appoints Veteran Pharma Executive Andreas Busch, PhD as Chief Innovation Officer
Blog Posts, Drug & Target Discovery, Science Blogs, Science content
Antibody Drug Conjugates: ‘Intelligent Drugs that Seek and Destroy Cancer’
Absci Reports Third Quarter 2022 Financial Results
Announcements
Absci to Participate in the Morgan Stanley Global Healthcare Conference
Absci to Participate at the Inaugural Gilmartin Group Emerging Growth Company Showcase
